142 related articles for article (PubMed ID: 19591904)
1. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.
Ryu JK; Jantaratnotai N; McLarnon JG
Neuroscience; 2009 Oct; 163(2):601-8. PubMed ID: 19591904
[TBL] [Abstract][Full Text] [Related]
2. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult.
Ryu JK; McLarnon JG
J Neuroinflammation; 2008 May; 5():18. PubMed ID: 18492281
[TBL] [Abstract][Full Text] [Related]
3. Depletion of neutrophils reduces neuronal degeneration and inflammatory responses induced by quinolinic acid in vivo.
Ryu JK; Tran KC; McLarnon JG
Glia; 2007 Mar; 55(4):439-51. PubMed ID: 17203474
[TBL] [Abstract][Full Text] [Related]
4. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.
Ryu JK; Choi HB; McLarnon JG
Neurobiol Dis; 2005 Nov; 20(2):550-61. PubMed ID: 15916899
[TBL] [Abstract][Full Text] [Related]
5. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
6. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu JK; Choi HB; McLarnon JG
Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum.
Lehrmann E; Molinari A; Speciale C; Schwarcz R
Exp Brain Res; 2001 Dec; 141(3):389-97. PubMed ID: 11715084
[TBL] [Abstract][Full Text] [Related]
8. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults.
Hanbury R; Ling ZD; Wuu J; Kordower JH
J Comp Neurol; 2003 Jun; 461(3):307-16. PubMed ID: 12746870
[TBL] [Abstract][Full Text] [Related]
9. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
Bazzett TJ; Becker JB; Kaatz KW; Albin RL
Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
[TBL] [Abstract][Full Text] [Related]
10. Delayed neurodegeneration and early astrogliosis after excitotoxicity to the aged brain.
Castillo-Ruiz MM; Campuzano O; Acarin L; Castellano B; Gonzalez B
Exp Gerontol; 2007 Apr; 42(4):343-54. PubMed ID: 17126514
[TBL] [Abstract][Full Text] [Related]
11. Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum.
Nam E; Lee SM; Koh SE; Joo WS; Maeng S; Im HI; Kim YS
Brain Res; 2005 Jun; 1046(1-2):90-6. PubMed ID: 15882841
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes.
Björklund H; Olson L; Dahl D; Schwarcz R
Brain Res; 1986 Apr; 371(2):267-77. PubMed ID: 2938667
[TBL] [Abstract][Full Text] [Related]
13. Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.
Gramsbergen JB; van der Sluijs-Gelling AJ
Exp Neurol; 1993 Jun; 121(2):261-9. PubMed ID: 8339777
[TBL] [Abstract][Full Text] [Related]
14. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
15. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome.
Roberts RC; Ahn A; Swartz KJ; Beal MF; DiFiglia M
Exp Neurol; 1993 Dec; 124(2):274-82. PubMed ID: 8287926
[TBL] [Abstract][Full Text] [Related]
16. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats.
Deshpande SB; Hida H; Takei-Io N; Masuda T; Baba H; Nishino H
Brain Res; 2006 Sep; 1108(1):205-15. PubMed ID: 16857175
[TBL] [Abstract][Full Text] [Related]
17. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum.
Qin ZH; Wang Y; Chen RW; Wang X; Ren M; Chuang DM; Chase TN
J Pharmacol Exp Ther; 2001 Apr; 297(1):78-87. PubMed ID: 11259530
[TBL] [Abstract][Full Text] [Related]
19. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage.
Menei P; Pean JM; Nerrière-Daguin V; Jollivet C; Brachet P; Benoit JP
Exp Neurol; 2000 Jan; 161(1):259-72. PubMed ID: 10683292
[TBL] [Abstract][Full Text] [Related]
20. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
